Lynparza 100 MG tablet UU 120S
Ended Awarded
- Contract number
- SPE2DB25FNWNL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,039
Award facts
- Contract value 100% obligated
- $21,039.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,039.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 100 mg tablets (120-count units) with an ultimate completion date of October 6, 2025. This non-set-aside contract was competitively awarded on September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this delivery order under its broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
The delivery order represents a typical transaction within AmerisourceBergen's extensive portfolio of pharmaceutical and medical supply deliveries to defense and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical IDC, the contractor supplies a broad spectrum of medications and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. The firm fixed-price structure and competitive award indicate AmerisourceBergen's continued capability to meet federal procurement requirements for specialized pharmaceutical products, including oncology medications such as Lynparza, which supports the Defense Health Agency and other government healthcare system customers.
Quick answers
Who was awarded contract SPE2DB25FNWNL?
SPE2DB25FNWNL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FNWNL worth?
The government has obligated $21,039 on SPE2DB25FNWNL.
Is contract SPE2DB25FNWNL an order under another contract?
Yes. SPE2DB25FNWNL is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWNL competed?
The extent of competition for SPE2DB25FNWNL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award